An Wouters

3.1k citations

73 papers · 2.2k indexed · 1 hit paper · h-index 27

Molecular Biology top 10%
Oncology top 5%
Cancer Research top 5%
Pulmonary and Respiratory Medicine top 10%
Immunology top 10%

Co-authors: Filip Lardon Marc Peeters Patrick Pauwels Jan B. Vermorken Bea Pauwels Christophe Deben Evelien Smits Jorrit De Waele
Topics: Cancer-related Molecular Pathways (17 papers)Lung Cancer Treatments and Mutations (17 papers)Cancer, Hypoxia, and Metabolism (12 papers)
Cited by: Oncology Cancer Research Immunology
Journals: PLoS ONE Cancer Research Journal of Agricultural and Food Chemistry
Partner nations: Belgium Netherlands United Kingdom

In The Last Decade

An Wouters

70 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The potential and controversy of targeting STAT family members in cancer

2019 273 citations Yannick Verhoeven, Julie Jacobs et al. profile →

Peers

Countries citing papers authored by An Wouters

Since Specialization

Citations

This map shows the geographic impact of An Wouters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Wouters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Wouters more than expected).

Fields of papers citing papers by An Wouters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An Wouters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Wouters. The network helps show where An Wouters may publish in the future.

Co-authorship network of co-authors of An Wouters

This figure shows the co-authorship network connecting the top 25 collaborators of An Wouters. A scholar is included among the top collaborators of An Wouters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An Wouters. An Wouters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Powering immunity: mitochondrial dynamics in natural killer cells 2025 ·Trends in Molecular Medicine ·(unknown),An Wouters,Evelien Smits,Jorrit De Waele	2
2	Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma 2025 ·OncoImmunology ·(unknown),Jonas R.M. Van Audenaerde,(unknown),Jorrit De Waele,(unknown),Christophe Hermans,(unknown),Céline Merlin,Maria Ribas,Peter Ponsaerts,Steven Van Laere,Filip Lardon,An Wouters,Scott Fisher,Jan P. van Meerbeeck,Elly Marcq,Evelien Smits	0
3	The prognostic impact of the immune signature in head and neck squamous cell carcinoma 2022 ·Frontiers in Immunology ·(unknown),Vasiliki Siozopoulou,(unknown),Christophe Hermans,(unknown),Hilde Lambrechts,Erik Fransén,Ines De Pauw,Julie Jacobs,Marc Peeters,Patrick Pauwels,Jan B. Vermorken,Evelien Smits,Filip Lardon,Jorrit De Waele,An Wouters	13
4	Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer 2021 ·Cancers ·Andreas Domen,Delphine Quatannens,Sara Zanivan,Christophe Deben,Jonas R.M. Van Audenaerde,Evelien Smits,An Wouters,Filip Lardon,Geert Roeyen,Yannick Verhoeven,Annelies Janssens,Timon Vandamme,Peter A. van Dam,Marc Peeters,Hans Prenen	42
5	Characterization of acquired nutlin-3 resistant non-small cell lung cancer cells 2021 ·Cancer Drug Resistance ·Christophe Deben,Laurie Freire Boullosa,Andreas Domen,An Wouters,Bart Cuypers,Kris Laukens,Filip Lardon,Patrick Pauwels	10
6	The art of obtaining a high yield of cell-free DNA from urine 2020 ·PLoS ONE ·(unknown),(unknown),Laure Sorber,Peter A. van Dam,Geert Roeyen,Marc Peeters,Alex Vorsters,An Wouters,Jo Raskin,Christian Rolfo,Karen Zwaenepoel,Patrick Pauwels	43
7	Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib 2019 ·Cancers ·Ines De Pauw,Filip Lardon,Jolien Van den Bossche,(unknown),Patrick Pauwels,Marc Peeters,Jan B. Vermorken,An Wouters	14
8	Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 Status 2019 ·Cancers ·Jolien Van den Bossche,Andreas Domen,Marc Peeters,Christophe Deben,Ines De Pauw,Julie Jacobs,(unknown),Pol Specenier,Patrick Pauwels,Jan B. Vermorken,Filip Lardon,An Wouters	9
9	The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma 2019 ·Cancers ·Mohammad Krayem,(unknown),Ahmad Najem,An Wouters,Filip Lardon,Stéphane Simon,François Salès,Fabrice Journé,Ahmad Awada,Ghanem Ghanem,Dirk Van Gestel	20
10	Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress 2018 ·Cancers ·Christophe Deben,Vanessa Deschoolmeester,Jorrit De Waele,Julie Jacobs,Jolien Van den Bossche,An Wouters,Marc Peeters,Christian Rolfo,Evelien Smits,Filip Lardon,Patrick Pauwels	46
11	Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia 2017 ·Journal of Cancer ·Jolien Van den Bossche,Christophe Deben,Ken Op de Beeck,Vanessa Deschoolmeester,Christophe Hermans,Ines De Pauw,Julie Jacobs,Paul Van Schil,Jan B. Vermorken,Patrick Pauwels,Marc Peeters,Filip Lardon,An Wouters	12
12	MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients 2017 ·Journal of Cancer ·Christophe Deben,Ken Op de Beeck,Jolien Van den Bossche,Julie Jacobs,Filip Lardon,An Wouters,Marc Peeters,Guy Van Camp,Christian Rolfo,Vanessa Deschoolmeester,Patrick Pauwels	4
13	Efficacy Screening of Gloriosa Superba Extracts in a Murine Pancreatic Cancer Model Using ¹⁸ F-FDG PET/CT for Monitoring Treatment Response 2016 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown),Christel Vangestel,An Wouters,(unknown),Patrick Pauwels,Sigrid Stroobants,Sandra Apers,Filip Lardon,Luc Pieters,Steven Staelens	13
14	Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer 2016 ·World Journal of Clinical Oncology ·Nele Van Der Steen,Christophe Deben,Vanessa Deschoolmeester,An Wouters,Filip Lardon,Christian Rolfo,Paul Germonpré,Elisa Giovannetti,Godefridus J. Peters,Patrick Pauwels	9
15	Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor. 2015 ·PubMed Central ·Carolien Boeckx,(unknown),Ken Op de Beeck,Ridha Limame,Guy Van Camp,Marc Peeters,Jan B. Vermorken,Pol Specenier,An Wouters,Marc Baay,Filip Lardon	24
16	In vitro and in vivo investigations on the antitumour activity of Chelidonium majus 2015 ·Phytomedicine ·(unknown),An Wouters,Filip Lardon,Claudia Gravekamp,Sandra Apers,Luc Pieters	40
17	The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein 2014 ·BMC Cancer ·An Wouters,Bea Pauwels,Natalie Burrows,Marc Baay,Vanessa Deschoolmeester,Trung Nghia Vu,Kris Laukens,Paul Meijnders,Dirk Van Gestel,Kaye J. Williams,Daniëlle Van den Weyngaert,Jan B. Vermorken,Patrick Pauwels,Marc Peeters,Filip Lardon	7
18	Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response 2014 ·BMC Research Notes ·Carolien Boeckx,Christine Weyn,Isabelle Vanden Bempt,Vanessa Deschoolmeester,An Wouters,Pol Specenier,Carl Van Laer,Daniëlle Van den Weyngaert,Mark Kockx,Jan B. Vermorken,Marc Peeters,Patrick Pauwels,Filip Lardon,Marc Baay	27
19	Pharmacological Levels of Withaferin A (Withania somnifera) Trigger Clinically Relevant Anticancer Effects Specific to Triple Negative Breast Cancer Cells 2014 ·PLoS ONE ·Katarzyna Szarc vel Szic,Ken Op de Beeck,Dariusz Ratman,An Wouters,Ilse M. Beck,Ken Declerck,Karen Heyninck,Erik Fransén,Marc Bracke,Karolien De Bosscher,Filip Lardon,Guy Van Camp,Wim Vanden Berghe	74
20	Counting clonogenic assays from normoxic and anoxic irradiation experiments manually or by using densitometric software 2010 ·Physics in Medicine and Biology ·An Wouters,Bea Pauwels,Hilde Lambrechts,G Pattyn,(unknown),Marc Baay,Paul Meijnders,Filip Lardon,Jan B. Vermorken	16

About An Wouters

An Wouters is a scholar working on Oncology, Cancer Research and Biotechnology, having authored 73 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (17 papers), Lung Cancer Treatments and Mutations (17 papers) and Cancer, Hypoxia, and Metabolism (12 papers). The work is most often cited by research in Oncology (965 citations), Cancer Research (497 citations) and Immunology (355 citations). An Wouters has collaborated with scholars based in Belgium, Netherlands and United Kingdom. Frequent co-authors include Filip Lardon, Marc Peeters, Patrick Pauwels, Jan B. Vermorken, Bea Pauwels, Christophe Deben, Evelien Smits, Jorrit De Waele, Vanessa Deschoolmeester and Julie Jacobs. Their work appears in journals such as PLoS ONE, Cancer Research and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact